Search clinical trials for: FE 999049

Total 97 results

Ferring Pharmaceuticals

Completed

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Infertility

Belgium, Denmark, Spain, Czechia
Ferring Pharmaceuticals

Completed

Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND) (BEYOND)

Infertility, Female

Norway, Israel, Denmark, Netherlands, Italy, Austria, Switzerland
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women

Infertility

Japan
University of Guadalajara

Completed

Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion

Diabetes Mellitus Type 2

Mexico
Ferring Pharmaceuticals

Completed

A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing

Colon Cleansing in Preparation for Colonoscopy

Japan
Ferring Pharmaceuticals

Completed

A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment

Infertility

Japan
Ferring Pharmaceuticals

Recruiting

A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)

Male Idiopathic Infertility

Denmark, United States, Sweden, Belgium, Spain, Italy, Germany
Ferring Pharmaceuticals

Recruiting

A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China (COCO)

Infertility, Female

China
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2 (ESTHER-2)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Ferring Pharmaceuticals

Completed

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1 (ESTHER-1)

Infertility

Canada, Belgium, Brazil, Czechia, Denmark, France, Italy, Poland, Russian Federation, Spain, United Kingdom
Ferring Pharmaceuticals

Completed

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) (RITA-1)

Infertility

United States
Ferring Pharmaceuticals

Completed

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) (RITA-2)

Infertility, Female

United States
Ferring Pharmaceuticals

Completed

Rekovelle PK Trial in Chinese Women

Infertility

China
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women

Controlled Ovarian Simulation

Korea, Republic of, Taiwan, China, Vietnam
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in India Women (IRIS)

Infertility

India
Ferring Pharmaceuticals

Completed

Efficacy, Pharmacokinetics and Safety of Testosterone

Testicular Hypogonadism

United States
Ferring Pharmaceuticals

Completed

A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel

Adult Male Hypogonadism

United States, Canada
Changchun Intellicrown Pharmaceutical Co. LTD

Recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects

Nonalcoholic Steatohepatitis (NASH)

China
Swiss Federal Institute of Technology
United States Agency for International Development (USAID); Quadram Institute... and other collaborators

Completed

IP Peru, Bioavailability of Iron From Potatoes (IPPERU)

Iron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)

Peru
GlyPharma Therapeutics
VectivBio AG

Withdrawn

Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas

Lymphoma, Non-Hodgkin's, Adult | Lymphoma, Hodgkin's, Adult
Ferring Pharmaceuticals

Completed

The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer

Prostate Cancer

United Kingdom
Ferring Pharmaceuticals

Completed

Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome

Hyperphagia in Prader-Willi Syndrome

United States
Swiss Federal Institute of Technology
University of Malawi

Completed

Iron Bioavailability From Biofortified Orange-fleshed Sweet Potato (SASHA-II)

Iron-deficiency | Iron Deficiency Anemia

Malawi, Switzerland
Ferring Pharmaceuticals

Terminated

A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension

Portal Hypertension

Spain
Ferring Pharmaceuticals

Completed

Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis (QLARITY)

Endometriosis

Germany, Poland, Denmark, Italy
Ferring Pharmaceuticals

Completed

A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment

Luteal Hormone Supplementation

Japan
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium (CAMOMILLE)

Meningioma

France
IRCCS San Raffaele

Completed

Prognostic Values of PET Examination With 11 C-Fe_CIT With Voxel-based Analysis Method in Patients With Sporadic Parkonson's Disease and Parkinsonisms (Prot.PD-diagn).

Parkinson Disease
Swiss Federal Institute of Technology

Completed

Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma

Malaria, Falciparum | Hookworm Infections | Schistosoma Haematobium

Côte D'Ivoire
Ferring Pharmaceuticals

Completed

Effects of the V1a Agonist FE 202158 in Patients With Septic Shock

Septic Shock

Denmark, United States, Belgium, Canada
Sichuan Enray Pharmaceutical Sciences Company

Recruiting

Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor (CNSI-Fe(II))

Cervical Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Advanced Solid Tumor | Pancreas Cancer | Thyroid Cancer | Vulva Cancer

China
Galapagos NV

Completed

A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Inflammatory Diseases

Healthy

Netherlands
Vigonvita Life Sciences

Recruiting

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Schizophrenia

China
University of Edinburgh
NHS Lothian

Completed

Exploratory Study of Intrapulmonary Microdosing of Gram-negative Optical Imaging Detection Probe (BAC TWO)

Respiratory Infections

United Kingdom
Ferring Pharmaceuticals

Recruiting

Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer

Japan
Far East Bio-Tec Co., Ltd

Unknown

Study to Investigate the Efficacy and Safety of Apomivir®

Influenza

Taiwan
Société des Produits Nestlé (SPN)

Completed

Iron Bioavailability From Dairy Product

Healthy Volunteers

Switzerland
Ferring Pharmaceuticals

Completed

A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. (RAINBOW)

Controlled Ovarian Stimulation

United Kingdom, Denmark, Belgium, Czechia, Spain
Ferring Pharmaceuticals

Completed

Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain (RAQUEL)

Endometriosis-related Pain

United States
Ferring Pharmaceuticals

Recruiting

A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Persons

Inflammatory Gastrointestinal Diseases

Germany
The Cleveland Clinic

Active, not recruiting

The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis

Multiple Sclerosis

United States
Ferring Pharmaceuticals

Completed

Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock

Septic Shock

Denmark, Belgium
Ferring Pharmaceuticals

Completed

Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine Contractions (BASIC)

Infertility

Belgium, Spain, Australia, Canada, Czech Republic, Poland
Ferring Pharmaceuticals

Terminated

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (MERMAID)

Preterm Delivery | Inadequate Milk Production

United States
University of Colorado, Denver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); International... and other collaborators

Completed

Effect of Sprinkles With and w/o Fe on Zn Absorption in Kenyan Toddlers

Micronutrient Deficiencies

United States, Kenya
Scott and White Hospital & Clinic
Warner Chilcott

Completed

Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills)

Pelvic Pain | Headaches | Emotional

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of SYHA1402 in Healthy Subjects

Diabetic Peripheral Neuropathy
Hacettepe University

Completed

Comparison of Ferrous Sulfate, Polymaltose Complex and Iron-zinc in Iron Deficiency Anemia

Iron Deficiency Anemia

Turkey
Cornell University
St. John's Research Institute; SNDT Women's University; Center for the Study...

Completed

Effect of Iron/Zinc-Biofortified Pearl Millet on Growth and Immunity in Children Aged 12-18 Months in India

Iron Deficiency | Zinc Deficiency

India
Medical Research Council

Completed

A Pilot Study to Assess the Influence of Dietary Organic Acids on Iron Absorption.

Iron Deficiency Anaemia

United Kingdom

3

Subscribe